An interventional study of Blood samples (36 mL) + fecal samples + hair sample in Schizophrenia Prodromal, Schizophrenia, Childhood and Schizophrenia, sponsored by University Hospital, Brest. Recruiting at 1 site in France. Open to participants aged 15 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-06-26.
Sponsored by University Hospital, Brest · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Establishment of a patient library for patients who have had a first psychotic episode and who have an "at risk" status for psychotic disorder (GRD, APS, BLIPS group) or a psychosis threshold during CAARMS administration. Samples are taken on inclusion, at 2 years, and if relapse or significant clinical event within 5 years of inclusion, on 250 patients for 10 years.
The constitution of this patient library will include results of clinical tests carried out in current practice, neurocognitive tests, blood samples, audio recordings, clinical follow-up, urine samples, fecal samples, brain imaging, EEG.
49 studies on the registry are indexed under Schizotypal Personality Disorder; 12 are open to participants now.
This study's planned enrollment of 250 is above the median of 54 across 41 interventional studies indexed under Schizotypal Personality Disorder.
Browse Schizotypal Personality Disorder studies →University Hospital, Brest is the lead sponsor of 602 studies on the registry; 137 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All the patients are included in one arm. They will undergo various type of samples.
Other: Blood samples (36 mL) + fecal samples + hair sample
Blood samples at inclusion, 2 years later and/or if relapse, fecal samples at inclusion and every years for 5 years, hair sample at inclusion
Also known as: Patient library
CAARMS (Comprehensive assessment of at-risk mental states) score.
The test will determine the mental state of the patient : * "Not at risk of psychosis" * "At risk of psychosis" * "Psychosis threshold exceeded" It is organized into 7 clinical dimensions: 1) positive symptoms 2) cognitive changes: attention / concentration 3) emotional disturbance 4) negative symptoms 5) behavioral change 6) physical and motor changes 7) general psychopathology. Each category is scored between 0 and 6 depending on the level of intensity, frequency and duration of each symptom. In order to determine if a subject meets the UHR criteria for CAARMS, only the first category (positive symptoms) and its four subscales are used according to a scoring algorithm.
Time frame: 5 years
CAARMS sub-assemblies
If the patient is classified at risk of psychosis, the test will classify this risk into one of the three following categories : trait and state risk factor group, APS (attenuated psychotic symptoms) group, BLIPS (Brief, Limited or Intermittent Psychotic Symptoms) group.
Time frame: 5 years
Plan to share: Yes — All collected data that underlie results in a publication
Supporting information: Study protocol
Time frame: Data will be available after the publication of result and ending fifteen years following the last visit of the last patient
Access criteria: Data access requests will be reviewed by the internal committee of Brest University Hospital (UH). Requestors will be required to sign and complete a data access agreement.
No publications or documents are linked to this record.
Started Jul 2022 (actual). Primary completion is estimated for Jul 2032, 120 months after the start.
Of 20 interventional studies with no phase under Schizotypal Personality Disorder, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 120 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Schizotypal Personality Disorder →